No retrievable evidence on the effectiveness of Isoprinosine in treating COVID-19.
RCT (2016) showed no statistical difference in the time to resolution all influenza-like
symptoms between Isoprinosine and placebo in patients with acute respiratory infections.
Nasiel som studiu na 60 ludoch, hned na zaciatku stranky je uvedene:
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.


